Literature DB >> 25878347

Quick Detection of FKS1 Mutations Responsible for Clinical Echinocandin Resistance in Candida albicans.

Catiana Dudiuk1, Soledad Gamarra2, Cristina Jimenez-Ortigosa3, Florencia Leonardelli1, Daiana Macedo2, David S Perlin3, Guillermo Garcia-Effron4.   

Abstract

A rapid molecular-based assay for the detection of the Candida albicans FKS1 gene mutations responsible for resistance to echinocandin drugs was designed and evaluated. The assay consisted of a multiplexed PCR set of 5 tubes able to detect the most commonly described resistance mechanism, including FKS1 hot spot 1 and hot spot 2 mutations. The performance and specificity of the assay was evaluated using a double-blinded panel of 50 C. albicans strains. The assay showed a sensitivity of 96% and was able to detect all homozygous mutants included in the collection of strains, demonstrating that it is a robust, quick, and labor-saving method that is suitable for a routine clinical diagnostic laboratory.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25878347      PMCID: PMC4473184          DOI: 10.1128/JCM.00398-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts.

Authors: 
Journal:  Clin Microbiol Infect       Date:  2008-01-11       Impact factor: 8.067

Review 2.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

Review 3.  Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.

Authors:  David S Perlin
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

4.  Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.

Authors:  Matthew Morrell; Victoria J Fraser; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  Detection of caspofungin resistance in Candida spp. by Etest.

Authors:  Marie Desnos-Ollivier; Françoise Dromer; Eric Dannaoui
Journal:  J Clin Microbiol       Date:  2008-04-30       Impact factor: 5.948

Review 6.  Echinocandin resistance: an emerging clinical problem?

Authors:  Maiken C Arendrup; David S Perlin
Journal:  Curr Opin Infect Dis       Date:  2014-12       Impact factor: 4.915

7.  Epidemiology and prognostic factors of candidemia in cancer patients.

Authors:  Hung-Jen Tang; Wei-Lun Liu; Hsin-Lan Lin; Chih-Cheng Lai
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

8.  Epidemiology of candidemia in Latin America: a laboratory-based survey.

Authors:  Marcio Nucci; Flavio Queiroz-Telles; Tito Alvarado-Matute; Iris Nora Tiraboschi; Jorge Cortes; Jeannete Zurita; Manuel Guzman-Blanco; Maria Elena Santolaya; Luis Thompson; Jose Sifuentes-Osornio; Juan I Echevarria; Arnaldo L Colombo
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

9.  Nosocomial candidemia; risk factors and prognosis revisited; 11 years experience from a Norwegian secondary hospital.

Authors:  Jan-Erik Berdal; Rolf Haagensen; Trond Ranheim; Jørgen V Bjørnholt
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

10.  Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period.

Authors:  Arnaldo L Colombo; Thais Guimarães; Teresa Sukienik; Alessandro C Pasqualotto; Ricardo Andreotti; Flavio Queiroz-Telles; Simone A Nouér; Marcio Nucci
Journal:  Intensive Care Med       Date:  2014-08-01       Impact factor: 17.440

View more
  6 in total

1.  Dose escalation studies with caspofungin against Candida glabrata.

Authors:  Marianna Domán; Renátó Kovács; David S Perlin; Gábor Kardos; Rudolf Gesztelyi; Béla Juhász; Aliz Bozó; László Majoros
Journal:  J Med Microbiol       Date:  2015-06-30       Impact factor: 2.472

2.  Creation, characterization and utilization of Cryptococcus neoformans mutants sensitive to micafungin.

Authors:  Akio Toh-E; Misako Ohkusu; Kiminori Shimizu; Masashi Yamaguchi; Naruhiko Ishiwada; Akira Watanabe; Katsuhiko Kamei
Journal:  Curr Genet       Date:  2017-05-30       Impact factor: 3.886

Review 3.  Progress in the Diagnosis of Invasive Fungal Disease in Children.

Authors:  Adilia Warris; Thomas Lehrnbecher
Journal:  Curr Fungal Infect Rep       Date:  2017-05-02

4.  Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing.

Authors:  Kathrin Spettel; Wolfgang Barousch; Athanasios Makristathis; Iris Zeller; Marion Nehr; Brigitte Selitsch; Michaela Lackner; Peter-Michael Rath; Joerg Steinmann; Birgit Willinger
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

Review 5.  Rapid Antifungal Susceptibility Testing of Yeasts and Molds by MALDI-TOF MS: A Systematic Review and Meta-Analysis.

Authors:  Miriam Alisa Knoll; Hanno Ulmer; Cornelia Lass-Flörl
Journal:  J Fungi (Basel)       Date:  2021-01-18

Review 6.  Molecular Markers of Antifungal Resistance: Potential Uses in Routine Practice and Future Perspectives.

Authors:  Guillermo Garcia-Effron
Journal:  J Fungi (Basel)       Date:  2021-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.